Miwon is pleased to announce the launch of a new whitening peptide, DermaPepTM W220,
an innovative dipeptide specially designed for whitening skin care products.
DermaPepTM W220, as a MC-1R antagonist, strongly suppresses the melanogenesis by
deactivating the expression and production of pigmentation-related genes. In vitro studies.
DermaPepTM W220 significantly inhibited the melanin production and tyrosinase activity
and showed even more powerful activity than DermaPepTM UL. In vivo clinical study,
performed on 30 Asian volunteers, confirmed its efficacy following 8 weeks of application.
For further information,please check it in product section.